Cargando…
Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States
Acquired hemophilia A (AHA) is an ultra-rare autoimmune disorder caused by autoantibodies against factor VIII. It often presents with life-threatening bleeding to non-hemophilia experts, who have limited awareness of this condition. This review evaluated hemostatic management and identified barriers...
Autores principales: | Sharathkumar, Anjali, Mokdad, Ali G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937086/ https://www.ncbi.nlm.nih.gov/pubmed/36819387 http://dx.doi.org/10.7759/cureus.33927 |
Ejemplares similares
-
A Case of Acquired Hemophilia A and Congenital Hemophilia B
por: Fortier, Julia C, et al.
Publicado: (2022) -
An Interesting Case of Acquired Hemophilia A in an Elderly Patient Presenting with Hematuria
por: Mehta, Parth, et al.
Publicado: (2020) -
Spontaneous intramural hemorrhage in a patient with severe hemophilia A
por: Shan, Ken-Hsyuan, et al.
Publicado: (2014) -
Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies
por: Marino, Renato
Publicado: (2023) -
Recombinant FVIII: the milestone of modern hemophilia treatment
por: Mannucci, Pier Mannuccio
Publicado: (2023)